Clinical Trials Directory

Trials / Completed

CompletedNCT00256802

The Diameter of the Middle Cerebral Artery Measured With Magnetic Resonance Angiography

The Diameter of the Middle Cerebral Artery Measured With Magnetic Resonance Angiography (MRA) Under Provocation With Glyceryl Trinitrate in Healthy Volunteers.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (planned)
Sponsor
Danish Headache Center · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

To examine the ability of MRA to measure the effect of GTN on the intra-cranial vascular response during the GTN-induced headache in healthy volunteers.

Detailed description

The only intra cranial structures innervated by sensory nerves, and therefore a possible source of the headpain are the meninges and the large intracerebral arteries. The dilatation of the cerebral vessels may not be the origin of the head pain per se, but measurements of the intra cerebral vascular bed in the past has proven valuable in the migraine-research, and has helped elucidate the basis for the migraine aura (Olesen, Friberg et al. 1990). The effects of different signal molecules on the intra cerebral vasculature continue to be an important field in the migraine research, in the search for possible pain causing signaling molecules. Therefore we have set up at study to examine if MR-Angiography (MRA) can be used for monitoring of the vascular response after challenge with the known vasodilator GTN. This drug was chosen because it is well characterized and a large body of evidence from earlier studies could serve as background data (Thomsen 1997).

Conditions

Interventions

TypeNameDescription
DEVICEMR-angiography, GTN

Timeline

Start date
2004-06-01
Completion
2005-01-01
First posted
2005-11-22
Last updated
2009-04-01

Source: ClinicalTrials.gov record NCT00256802. Inclusion in this directory is not an endorsement.